The Jakarta Post - The country’s largest drug maker, PT Kalbe Farma, has set aside up to Rp 1.7 trillion (US$149.4 million) of its internal cash for business expansion this year.

Kalbe external communications manager Hari Nugroho said after a shareholders meeting on Wednesday that the company would spend between Rp 1 trillion and 1.2 trillion on capital expenditure to boost its production capacity and expand distribution channels.

Read more...